// App-Quantinova.ai

1737 : Additional Chromosomal Abnormalities in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated with Tyrosine Kinase Inhibitors: Differential Outcomes According to Type of Chromosomal Abnormality

Researchers

Presenter

  • Nicholas J. Short

Principal Investigators

  • Koji Sasaki

  • Guillermo Garcia-Manero

  • Deborah A Thomas

  • Naval Daver

  • Kiran Naqvi

  • Prithviraj Bose

  • Nitin Jain

  • Marina Konopleva

  • Hagop M. Kantarjian

  • Heidi Ko

  • Farhad Ravandi

  • C. Cameron Yin

  • Maria R. Khouri

  • Jorge E. Cortes

  • Rebecca Garris

  • Susan M. -Brien

  • Keyur P. Patel

Medical Centers

  • Chao Family Comprehensive Cancer Center, University of California, Orange, CA

  • Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Nanomedicine, University of Texas Health Science Center at Houston, Houston, TX.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Ph chromosome

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved